Nozari Neda
Researcher, Digestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran ; Shahid Rajai Hospital, Alborz University of Medical Sciences, Karaj, Iran.
Middle East J Dig Dis. 2017 Jan;9(1):55-57. doi: 10.15171/mejdd.2016.52.
Type II enteropathy-associated T-cell lymphoma (EATL) is a rare disease that is reported from Asia, especially from Taiwan. In this paper, we present a patient from Iran (Arab) with Type II EATL whose disease was not associated with celiac disease or Epstein-Barr virus (EBV) infection. The patient died due to intestinal perforation during the first chemotherapy. Type II EATL is a gastrointestinal lymphoma with poor prognosis and a high affinity for intestinal perforation. Early detection of EATL II is essential for chemotherapy prior to the onset of malnutrition symptoms.
II型肠病相关T细胞淋巴瘤(EATL)是一种罕见疾病,在亚洲尤其是台湾地区有相关报道。在本文中,我们介绍了一名来自伊朗(阿拉伯族)的II型EATL患者,其疾病与乳糜泻或爱泼斯坦-巴尔病毒(EBV)感染无关。该患者在首次化疗期间因肠穿孔死亡。II型EATL是一种预后较差且极易发生肠穿孔的胃肠道淋巴瘤。早期发现II型EATL对于在营养不良症状出现之前进行化疗至关重要。